JHSF Participações S.A. (BVMF:JHSF3)

CTI BioPharma Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,454	2,474	3,776	3,333	3,802	5,367
Market Cap Growth	-14.37%	-34.48%	13.29%	-12.34%	-29.16%	17.98%
Enterprise Value	7,297	5,827	6,908	5,541	5,079	5,918
Last Close Price	5.16	3.51	4.90	4.01	4.29	5.64
PE Ratio	3.28	2.90	8.34	5.19	3.79	8.34
Forward PE	5.91	3.75	5.83	5.75	6.07	34.08
PS Ratio	2.01	1.54	2.37	1.72	1.89	4.59
PB Ratio	0.56	0.42	0.72	0.67	0.84	1.40
P/TBV Ratio	0.61	0.47	0.81	0.72	0.87	1.48
P/OCF Ratio	12.13	7.50	31.50	-	9.72	30.97
PEG Ratio	-	0.32	0.32	0.32	0.32	0.32
EV/Sales Ratio	4.25	3.62	4.34	2.86	2.53	5.06
EV/EBITDA Ratio	10.15	9.32	11.59	6.47	4.43	9.17
EV/EBIT Ratio	10.99	10.04	12.29	6.99	4.60	9.44
EV/FCF Ratio	-24.61	-	-	-	-	-
Debt / Equity Ratio	0.86	0.80	0.65	0.61	0.49	0.44
Debt / EBITDA Ratio	7.55	7.26	5.58	3.58	1.91	2.59
Asset Turnover	0.13	0.13	0.15	0.21	0.26	0.18
Inventory Turnover	0.49	0.50	0.55	1.06	2.35	1.80
Quick Ratio	1.36	1.08	1.24	2.54	2.09	1.50
Current Ratio	2.10	1.75	2.18	4.08	2.42	1.73
Return on Equity (ROE)	18.35%	15.58%	9.74%	13.48%	23.44%	18.56%
Return on Assets (ROA)	3.06%	2.98%	3.30%	5.33%	8.79%	5.98%
Return on Capital (ROIC)	3.87%	3.79%	4.21%	6.69%	11.24%	7.95%
Return on Capital Employed (ROCE)	5.30%	5.30%	5.70%	8.40%	14.60%	10.10%
Earnings Yield	30.93%	34.53%	11.98%	19.27%	26.39%	11.99%
FCF Yield	-8.59%	-7.51%	-3.06%	-23.31%	-0.83%	-2.50%
Dividend Yield	7.22%	-	7.52%	4.78%	8.02%	-
Payout Ratio	23.40%	29.26%	66.73%	22.03%	26.84%	17.95%
Buyback Yield / Dilution	0.50%	0.52%	1.16%	0.34%	-3.62%	-20.00%
Total Shareholder Return	7.72%	0.52%	8.68%	5.12%	4.40%	-20.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.